Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

0.9851 -0.0449 (-4.36%)

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Volume	125,380
Open	1.030
Bid (Size)	0.9500 (100)
Ask (Size)	1.040 (100)
Prev. Close	1.030
Today's Range	0.9615 - 1.073
52wk Range	1.010 - 6.960
Shares Outstanding	12,000,585
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

September 17, 2026

Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. Markets

From NeuroOne Medical Technologies Corporation

Via GlobeNewswire

BioMedNewsBreaks — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform

August 27, 2026

Via Investor Brand Network

Performance

YTD	-80.7%	-80.7%
1 Month	-42.1%	-42.1%
3 Month	-67.2%	-67.2%
6 Month	-79.5%	-79.5%
1 Year	-81.5%	-81.5%

More News

NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform

August 27, 2026

Via NewMediaWire

NeuroOne (NMTC) Q3 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

NeuroOne (NMTC) Q2 2026 Earnings Transcript ↗

June 01, 2026

Via The Motley Fool

NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗

May 12, 2026

Via Chartmill

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%

August 13, 2026

Via NewMediaWire

NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification

August 11, 2026

Via NewMediaWire

NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time

August 03, 2026

Via NewMediaWire

NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform

July 30, 2026

Via NewMediaWire

NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians

July 28, 2026

Via NewMediaWire

NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial

July 16, 2026

Via NewMediaWire

NeuroOne(R) Added to Russell Microcap(R) Index

June 29, 2026

Via NewMediaWire

NeuroOne(R) Added to Russell Microcap(R) Index

June 29, 2026

Via TheNewswire.com

NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 25, 2026

Via NewMediaWire

NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 25, 2026

Via TheNewswire.com

NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index

June 16, 2026

Via TheNewswire.com

NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index

June 16, 2026

Via NewMediaWire

NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time

June 08, 2026

Via TheNewswire.com

NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time

June 08, 2026

Via NewMediaWire

NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026

May 28, 2026

Via NewMediaWire

NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026

May 28, 2026

Via TheNewswire.com

NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026

May 22, 2026

Via NewMediaWire

NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026

May 22, 2026

Via TheNewswire.com

NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update

May 12, 2026

Via NewMediaWire

Frequently Asked Questions

Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?

Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.

What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?

NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?

The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market

What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?

The current price of NeuroOne Medical Technologies Corporation - Common Stock is 0.9851

When was NeuroOne Medical Technologies Corporation - Common Stock last traded?

The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 10/01/26 04:00 PM ET

What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?

The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 11.82M

How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?

NeuroOne Medical Technologies Corporation - Common Stock has 12M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.